Treatment Method Using Plasma Fibroblasts: Advantages and Disadvantages
Plasma fibroblast therapy is a novel, non-surgical skin-tightening procedure that has been gaining popularity due to its potential to improve the appearance of the skin. The treatment uses a plasma pen device to create small, superficial wounds on the skin's surface, stimulating the activity of fibroblasts—cells responsible for collagen and elastin production.
The procedure aims to tighten the skin in various areas, including the face, neck, arms, breasts, stomach, buttocks, thighs, and knees. By promoting skin regeneration, it can help reduce the appearance of fine lines, wrinkles, and sagging, especially around delicate areas like eyes, mouth, and neck.
How Does Plasma Fibroblast Therapy Work?
The plasma fibroblast therapy process involves a small plasma discharge to create a small wound in the skin, followed by a symmetrical grid application to encourage fibroblast activity and skin tightening. This controlled micro-injury induces collagen production, leading to gradual skin tightening and improved texture.
Effectiveness of Plasma Fibroblast Therapy
While the evidence supporting plasma fibroblast therapy is still emerging, it is generally considered a promising, non-invasive treatment for mild to moderate skin laxity. The therapy is reported to achieve mild to moderate tightening, with an immediate tightening effect noticeable but true remodeling happening over time. Results can last up to several years but vary depending on individual factors such as age, skin type, and lifestyle.
Safety of Plasma Fibroblast Therapy
Plasma fibroblast therapy is generally considered safe and non-invasive, with side effects typically limited to mild redness, swelling, and temporary scabbing at treatment sites. The procedure avoids cutting, reducing risks of infection or scarring compared to traditional incisions.
Limitations and Scientific Gaps
Most evidence for plasma fibroblast therapy comes from clinical practice reports, anecdotal evidence, and aesthetic clinics rather than large-scale, peer-reviewed clinical trials. There is a lack of comprehensive randomized controlled trials directly comparing plasma fibroblast therapy to other skin tightening methods, such as laser or radiofrequency. More long-term safety and efficacy data are needed for definitive conclusions.
Cautions and Considerations
While plasma fibroblast therapy may pose risks from local anesthetics during the procedure, it is generally considered safe for individuals with Fitzpatrick skin types 1-3. Patch testing may be necessary for those with Fitzpatrick skin types 4 and above. People with systemic conditions, infections at the treatment site, open wounds, body dysmorphia, immunosuppression, autoimmune conditions, a tendency for scarring, or those living with a systemic condition should consult a healthcare professional before undergoing plasma fibroblast therapy.
Plasma fibroblast therapy is not advisable for self-administration at home and must undergo regulation by medical board ruling and FDA approval. Pregnant people, breastfeeding individuals, and those using isotretinoin for severe acne should not undergo plasma fibroblast therapy.
Conclusion
Plasma fibroblast therapy represents an innovative and increasingly popular skin tightening technique with supportive but still emerging scientific evidence. Rigorous clinical studies are needed to fully establish its comparative effectiveness and safety profile. Reputable healthcare professionals can be found on websites such as The Aesthetic Society, American Academy of Cosmetic Surgery, American Board of Cosmetic Surgery, and American Society of Plastic Surgeons.
- While plasma fibroblast therapy shows potential for improving the health-and-wellness of individuals with mild to moderate skin laxity, more comprehensive, large-scale, peer-reviewed clinical trials are needed to rectify the existing scientific gap.
- This predictive skin-care treatment, although generally recognized as safe and non-invasive, should be administered with caution in people with skin type 4 and above, necessitating patch testing before treatment.
- The therapy's efficacy varies among individuals, and despite the immediate tightening effect, the remodeling process occurs over time, leading to results that can last up to several years.
- Skin conditions such as eczema, or any underlying health issues like autoimmune conditions, immunosuppression, or systemic conditions, should be managed before considering plasma fibroblast therapy to avoid potential complications.
- In dry and delicate areas like the face, excessive collagen production could potentially lead to undesirable outcomes such as dryness, or even skin degeneration, emphasizing the importance of certified aesthetic professionals during the application process.
